Nature research paper: Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.SARS-CoV-2 Delta and Omicron are globally relevant variants of concern .
Noah Brazer, Prachi Saldhi, Alicia Sotomayor-Gonzalez, Venice Servellita, Amelia Gliwa, Jenny Nguyen & Charles Y. ChiuMauricio Montano & Warner C. Greene Ines Silva, Bilal Milbes, Noah Kojima, Victoria Hess, Maria Shacreaw, Lauren Lopez, Matthew Brobeck, Fred Turner & Lee SpraggonAshley F. George & Nadia R. Roan
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2 - NatureNature - Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2
Lire la suite »
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2 - NatureNature - Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2
Lire la suite »
FDA authorizes Pfizer Covid booster for children 5 to 11 years oldA study in February found that two doses of the vaccine offered little protection against the omicron variant.
Lire la suite »
South Africa in new surge of COVID from versions of omicronSouth Africa’s new cases have gone from an average of 300 per day in early April to about 8,000 per day this week. The new surge is from two variations of omicron, BA.4 and BA.5, which appear to be very much like the original strain of omicron.
Lire la suite »
North Korean leader Kim slams officials' 'immaturity' in response to COVID outbreakThe country has not started mass vaccinations and has limited testing capabilities.
Lire la suite »